Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices

JAMA

Volumn 307, Issue 16, 2012, Pages 1727-1735

  Athan, Eugene ^a   Chu, Vivian H ^a   Tattevin, Pierre ^a   Selton Suty, Christine ^a   Jones, Phillip ^a   Naber, Christoph ^a   Miró, José M ^a   Ninot, Salvador ^a   Fernández Hidalgo, Nuria ^a   Durante Mangoni, Emanuele ^a   Spelman, Denis ^a   Hoen, Bruno ^a   Lejko Zupanc, Tatjana ^a   Cecchi, Enrico ^a   Thuny, Franck ^a   Hannan, Margaret M ^a   Pappas, Paul ^a   Henry, Margaret ^a   Fowler, Vance G ^a   Crowley, Anna Lisa ^a   Wang, Andrew ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BACTERIAL ENDOCARDITIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; COHORT ANALYSIS; DEVICE INFECTION; DEVICE REMOVAL; DISEASE ASSOCIATION; FEMALE; HEART ASSIST DEVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; SURVIVAL TIME; TRICUSPID VALVE;

EID: 84860212453     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.497     Document Type: Article

References (31)

1. Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58(10):1001- 1006.
2. Jarcho JA. Biventricular pacing. N Engl J Med. 2006; 355(3):288-294. (Pubitemid 44079343)
3. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann Intern Med. 2000;133(8):604- 608.
4. Cabell CH, Heidenreich PA, Chu VH, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am Heart J. 2004; 147(4):582-586. (Pubitemid 38900441)
5. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004; 350(14):1422-1429. (Pubitemid 38419996)
6. Ferguson TB Jr, Ferguson CL, Crites K, Crimmins-Reda P. The additional hospital costs generated in the management of complications of pace-maker and defibrillator implantations. J Thorac Cardiovasc Surg. 1996;111(4):742-752. (Pubitemid 26118856)
7. Sohail MR, Uslan DZ, Khan AH, et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J Am Coll Cardiol. 2007;49(18):1851-1859. (Pubitemid 46661104)
8. Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation. 1997; 95(8):2098-2107. (Pubitemid 27184278)
9. Da Costa A, Lelièvre H, Kirkorian G, et al. Role of the preaxillary flora in pacemaker infections: a prospective study. Circulation. 1998;97(18):1791- 1795.
10. Klug D, Balde M, Pavin D, et al PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation. 2007;116 (12):1349-1355. (Pubitemid 47417560)
11. Duval X, Selton-Suty C, Alla F, et al; Association pour l'Etude et la Prevention de l'Endocardite Infectieuse. Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin Infect Dis. 2004;39(1):68-74. (Pubitemid 38879551)
12. Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007;167(7):669-675. (Pubitemid 46598459)
13. Chamis AL, Peterson GE, Cabell CH, et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter-defibrillators. Circulation. 2001;104(9):1029-1033. (Pubitemid 32803880)
14. Cacoub P, Leprince P, Nataf P, et al. Pacemaker infective endocarditis. Am J Cardiol. 1998;82(4): 480-484. (Pubitemid 28389947)
15. Arber N, Pras E, Copperman Y, et al. Pacemaker endocarditis: report of 44 cases and review of the literature. Medicine (Baltimore). 1994;73(6):299- 305.
16. Fowler VG Jr, Miró JM, Hoen B, et al ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005; 293(24):3012-3021. (Pubitemid 40965071)
17. Cabell CH, Jollis JG, Peterson GE, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med. 2002;162(1): 90-94. (Pubitemid 34073406)
18. Cabell CH, Abrutyn E. Progress toward a global understanding of infective endocarditis: early lessons from the International Collaboration on Endocarditis investigation. Infect Dis Clin North Am. 2002; 16(2):255-272. (Pubitemid 34663636)
19. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4): 633-638.
20. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137 (10):791-797. (Pubitemid 35334450)
21. Benito N, Miró JM, de Lazzari E, et al ICE-PCS (International Collaboration on Endocarditis-Prospective Cohort Study) Investigators. Health care-associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med. 2009; 150(9):586-594.
22. Daniel WG, Mügge A, Martin RP, et al. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography.NEngl J Med. 1991;324(12):795-800.
23. Sohail MR, Uslan DZ, Khan AH, et al. Infective endocarditis complicating permanent pacemaker and implantable cardioverter-defibrillator infection. Mayo Clin Proc. 2008;83(1):46-53.
24. Le KY, Sohail MR, Friedman PA, et al Mayo Cardiovascular Infections Study Group. Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin Electrophysiol. 2011;34(4):450-459.
25. Wang A, Athan E, Pappas PA, et al International Collaboration on Endocarditis-Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297(12):1354- 1361. (Pubitemid 46513236)
26. Murdoch DR, Corey GR, Hoen B, et al International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463-473.
27. Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation. 1998;97(18): 1796-1801. (Pubitemid 28213623)
28. Baman TS, Gupta SK, Valle JA, Yamada E. Risk factors for mortality in patients with cardiac device-related infection. Circ Arrhythm Electrophysiol. 2009; 2(2):129-134.
29. Baddour LM, Epstein AE, Erickson CC, et al American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Interdisciplinary Council on Quality of Care; American Heart Association. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458-477.
30. Massoure PL, Reuter S, Lafitte S, et al. Pace-maker endocarditis: clinical features and management of 60 consecutive cases. Pacing Clin Electrophysiol. 2007;30(1):12-19. (Pubitemid 46114923)
31. Greenspon AJ, Prutkin JM, Sohail MR, et al. Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis: results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort). J Am Coll Cardiol. 2012; 59(7):681-687.